youtube_live
Q3 2026 earnings • released • EPS beat +11,45% • Revenue beat +3,01%
See resultschevron_right
AMGN34:BVMF
Amgen Inc. BDR
R$90,62
0,00%
(0,00) 1D
3 Nov., 17:50:46 GMT-3 · BRL
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for AMGN34...
Open
R$91,17
High
R$91,49
Low
R$90,40
Mkt. cap
249,37 mjd
Avg. vol.
423,00
Volume
62,00
52-wk high
R$91,74
52-wk low
R$47,76
Shares outstanding
540,63 m
No. of employees
32 k
Open
R$91,17
High
R$91,49
Low
R$90,40
Mkt. cap
249,37 mjd
Avg. vol.
423,00
Volume
62,00
52-wk high
R$91,74
52-wk low
R$47,76
Shares outstanding
540,63 m
No. of employees
32 k
News stories
From web sources and news partners
BigGo Finance
·
55 minute gelede
AMGN Q3 FY2026 earnings call
Investing.com
·
1 uur gelede
Amgen Q3 2026 slides: six growth drivers fuel 8% revenue gain
scanx.trade
·
1 uur gelede
Amgen Q3FY26 Results: Revenue up 8% YoY to $10.4 billion
Bloomberg.com
·
1 uur gelede
Amgen Raises Revenue Forecast Again as Sales Top Expectations
Profile
Amgen Inc. is an American multinational biopharmaceutical company headquartered in Thousand Oaks, California. The company is ranked 18th on the list of largest biomedical companies by revenue. The name "AMGen" is a portmanteau of the company's original name, Applied Molecular Genetics.
The company's major products are Prolia and XGEVA to treat osteoporosis and bone diseases, Repatha to treat hyperlipidemia, Otezla to treat psoriasis and psoriatic arthritis, Enbrel to treat autoimmune diseases, Evenity to treat osteoporosis, Tepezza to treat Graves' ophthalmopathy, Blincyto to treat acute lymphoblastic leukemia, Nplate to regulate platelet production, Tezspire to treat asthma, Kyprolis to treat cancer, Aranesp to stimulate erythropoiesis, Krystexxa to treat gout, and Vectibix, a monoclonal antibody.
Amgen has 17 clinical programs underway in Phase III, eight in Phase II, and 19 in Phase I. Its pipeline includes MariTide, an anti-obesity medication administered once per month by injection.
The company receives approximately 80% of its revenues from sales to the three large U.S. drug wholesalers: McKesson Corporation, Cencora, and Cardinal Health. Wikipedia
About Amgen Inc. BDR
CEORobert A. Bradway
Employees31,5 k
Founded1980
HeadquartersThousand Oaks, Kalifornië, Verenigde State van Amerika
Sector-
Industry-
Websiteamgen.com